1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst's (LPA's) Vasallo and Mora conducted a subsequent complaint visit to investigate the allegation listed above. LPA's met with Executive Director, Kevin Taliaferro and explained the reason for the visit. The initial complaint visit was conducted on 8/29/19 by LPA Rivas.
The investigation consisted of the following: LPA Rivas conducted interviews with the facility Wellness Director, Resident #1 (R1), R1's private caregiver, and additional facility residents. LPA Rivas also reviewed R1's file and medications. During today's visit, LPA's reviewed R1's file. Interviews were conducted with R1 and the Wellness Director and Executive Director.
The investigation revealed the following: R1 was interviewed and R1 indicated they had no issues with the facility handling their medication and had no issues with paying the medication management fee. R1 did not recall ever having an issue with staff handling the medication or being forced to sign documents. Continued on 9099C. |